Raloxifene Lowers Serum Calcium and Markers of Bone Turnover in Postmenopausal Women with Primary Hyperparathyroidism
Year: 2003
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Institution: Columbia University
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: raloxifene, primary hyperparathyroidism, postmenopausal women, serum calcium, bone turnover markers, osteocalcin, N-telopeptide, estrogen replacement therapy, selective estrogen receptor modulators, bone resorption, parathyroid hormone, 1,25-dihydroxyvitamin D, alkaline phosphatase, urinary calcium excretion
Open Access status: closed
OpenAlex ID: W1970517193
